Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It also provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is headquartered in Thane, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Healthy return on equity of 18.6%
Concerns0
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ351.00 Cr | β | βΉ102.00 Cr | β | β | 16.2% | -3.8% | -5.6% |
| Mar 2024 | βΉ365.00 Cr | β | βΉ108.00 Cr | β | β | 18.6% | 17.0% | 92.9% |
| Mar 2023 | βΉ312.00 Cr | β | βΉ56.00 Cr | β | β | 10.7% | 14.3% | 1.8% |
| Mar 2022 | βΉ273.00 Cr | β | βΉ55.00 Cr | β | β | 11.5% | -3.5% | -22.5% |
| Mar 2021 | βΉ283.00 Cr | β | βΉ71.00 Cr | β | β | 16.3% | 14.6% | 22.4% |
| Mar 2020 | βΉ247.00 Cr | β | βΉ58.00 Cr | β | β | 15.7% | 11.3% | 65.7% |
| Mar 2019 | βΉ222.00 Cr | β | βΉ35.00 Cr | β | β | 11.0% | 4.7% | -2.8% |
| Mar 2018 | βΉ212.00 Cr | β | βΉ36.00 Cr | β | β | 12.5% | 22.5% | 2.9% |
| Mar 2017 | βΉ173.00 Cr | β | βΉ35.00 Cr | β | β | 13.7% | 24.5% | 66.7% |
| Mar 2016 | βΉ139.00 Cr | β | βΉ21.00 Cr | β | β | 12.1% | 11.2% | 5.0% |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 429 |
| Total Expenses | 332 |
| EBIT / Operating Profit | 96 |
| OPM % | 22% |
| Other Income | 63 |
| Finance Costs | 0 |
| Depreciation & Amortisation | 12 |
| Profit Before Tax | 147 |
| Tax % | - |
| Net Profit / PAT | 122 |
| EPS (βΉ) | 10.95 |
| Dividend Payout % | - |
Peer Comparison
Technology sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Advanced Enzyme Technologies Limitedthis co. | βΉ3.25 K Cr | βΉ351.00 Cr | 26.50 | 4.83 | 22.12 | -3.8% |
| Bharti Airtel Ltd. | βΉ12.19 L Cr | βΉ1.09 L Cr | 50.40 | 8.31 | 27.19 | 15.8% |
| Tata Consultancy Services Ltd. | βΉ11.84 L Cr | βΉ2.15 L Cr | 24.20 | 13.91 | 18.91 | 6.2% |
| Infosys Ltd | βΉ6.48 L Cr | βΉ1.37 L Cr | 24.20 | 7.17 | 16.31 | 5.9% |
| HCL Technologies Ltd | βΉ4.52 L Cr | βΉ51.10 K Cr | 36.80 | 14.48 | β | 6.2% |
| Bharat Electronics Ltd. | βΉ3.02 L Cr | βΉ23.66 K Cr | 53.30 | 14.23 | 51.32 | 17.3% |
| Wipro Ltd. | βΉ2.77 L Cr | βΉ67.29 K Cr | 23.00 | 4.29 | 18.85 | 0.8% |
| Industry Average | β | βΉ10.05 K Cr | 69.99 | 8.58 | 66.75 | 22.0% |